Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant
Recruiting
Dova Pharmaceuticals
Phase 2
2020-08-10
This phase II trial studies the side effects and how well avatrombopag works for the
treatment of thrombocytopenia after donor hematopoietic stem cell transplant.
Thrombocytopenia is defined as abnormally low level of platelets in the blood. Avatrombopag
is a small molecule thrombopoietin receptor agonist which stimulates thrombopoietin receptor
leading to increase production of platelets.
Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant
Recruiting
National Cancer Institute (NCI)
Phase 2
2020-08-10
This phase II trial studies the side effects and how well avatrombopag works for the
treatment of thrombocytopenia after donor hematopoietic stem cell transplant.
Thrombocytopenia is defined as abnormally low level of platelets in the blood. Avatrombopag
is a small molecule thrombopoietin receptor agonist which stimulates thrombopoietin receptor
leading to increase production of platelets.
Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant
Recruiting
Basem William, MD
Phase 2
2020-08-10
This phase II trial studies the side effects and how well avatrombopag works for the
treatment of thrombocytopenia after donor hematopoietic stem cell transplant.
Thrombocytopenia is defined as abnormally low level of platelets in the blood. Avatrombopag
is a small molecule thrombopoietin receptor agonist which stimulates thrombopoietin receptor
leading to increase production of platelets.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
